Helius Medical Technologies Inc (HSM.TO)
HSM.TO on Toronto Stock Exchange
12.51CAD
18 Sep 2018
12.51CAD
18 Sep 2018
Change (% chg)
-- (--)
-- (--)
Prev Close
$12.51
$12.51
Open
--
--
Day's High
--
--
Day's Low
--
--
Volume
--
--
Avg. Vol
13,939
13,939
52-wk High
$25.45
$25.45
52-wk Low
$9.00
$9.00
Revenue & Earnings Per Share
Consensus Estimates Analysis
No consensus analysis data available.
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 148.68 | 32.76 | |
| P/E High - Last 5 Yrs. | -- | 73.48 | 45.44 | |
| P/E Low - Last 5 Yrs. | -- | 21.21 | 24.26 | |
| Beta | -- | 0.92 | 0.89 | |
| Price to Sales (TTM) | -- | 10.42 | 5.75 | |
| Price to Book (MRQ) | -- | 4.10 | 5.00 | |
| Price to Tangible Book (MRQ) | -- | 5.02 | 6.57 | |
| Price to Cash Flow (TTM) | -- | 19.13 | 23.29 | |
| % Owned Institutions | -- | 25.13 | 2.21 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 0.77 | 1.51 | |
| Dividend Yield - 5 Year Avg | -- | 0.72 | 1.52 | |
| Dividend 5 Year Growth Rate | -- | 8.19 | 5.22 | |
| Payout Ratio(TTM) | -- | 25.17 | 43.78 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -- | 8.77 | 8.01 | |
| Sales (TTM) vs TTM 1 Yr. Ago | -- | 3.59 | 5.64 | |
| Sales - 5 Yr. Growth Rate | -- | 4.27 | 10.18 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | -- | 50.66 | 20.61 | |
| EPS (TTM) vs TTM 1 Yr. Ago | -- | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 5.27 | 10.66 | |
| Capital Spending - 5 Yr. Growth Rate | -- | 11.79 | 15.34 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 1.74 | 2.22 |
| Current Ratio (MRQ) | -- | 2.25 | 3.03 |
| LT Debt to Equity (MRQ) | -- | 40.30 | 12.51 |
| Total Debt to Equity (MRQ) | -- | 49.10 | 16.85 |
| Interest Coverage (TTM) | -- | 23.24 | 32.65 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | -- | 54.92 | 54.37 | |
| Gross Margin - 5 Yr. Avg. | -- | 54.68 | 52.17 | |
| EBITD Margin (TTM) | -- | -- | -- | |
| EBITD - 5 Yr. Avg | -- | 16.75 | 10.68 | |
| Operating Margin (TTM) | -- | -4.59 | 4.32 | |
| Operating Margin - 5 Yr. Avg. | -- | 8.56 | 6.11 | |
| Pre-Tax Margin (TTM) | -- | -4.17 | 5.18 | |
| Pre-Tax Margin - 5 Yr. Avg. | -- | 7.67 | 6.51 | |
| Net Profit Margin (TTM) | -- | -6.34 | 1.48 | |
| Net Profit Margin - 5 Yr. Avg. | -- | 5.46 | 2.78 | |
| Effective Tax Rate (TTM) | -- | 17.39 | 23.11 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 19.85 | 23.97 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | -- | 14,087,939 | 860,372,597 | |
| Net Income/Employee (TTM) | -- | 1,184,156 | 101,206,889 | |
| Receivable Turnover (TTM) | -- | 5.26 | 5.87 | |
| Inventory Turnover (TTM) | -- | 4.97 | 3.41 | |
| Asset Turnover (TTM) | -- | 0.77 | 0.94 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -- | -1.15 | 11.13 | |
| Return on Assets - 5 Yr. Avg. | -- | 4.95 | 12.40 | |
| Return on Investment (TTM) | -- | 9.38 | 14.61 | |
| Return on Investment - 5 Yr. Avg. | -- | 6.72 | 16.13 | |
| Return on Equity (TTM) | -- | 14.71 | 16.33 | |
| Return on Equity - 5 Yr. Avg. | -- | 9.60 | 17.39 | |
Note: Units in Millions of US Dollars
Performance for Helius Medical Technologies Inc
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
- BRIEF-Helius Medical - If Co Fails To Ensure Commercialization Of Pons Treatment Is Available For U.S. Government By Dec. 31, 2021, Co May Forfeit Right To Pursue Commercialization
- BRIEF-Helius Medical Technologies Announces Uplisting To Nasdaq And Pricing Of Public Offering Of Class A Common Stock And Warrants
Institutional Holders
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.